Editorially curated · sa-kfshrc-genomic-medicine-center
KFSHRC Genomic Medicine Center of Excellence Integrated Model
Integrates medical genomics, accredited laboratory testing, computational science/AI and translational genomics into routine care and research.
01 / Project overview
What the record establishes.
- Geographic scope
- KFSHRC patients and national referrals
- Project type
- Institutional genomic-medicine infrastructure and clinical implementation umbrella
- Research domain
- Medical genomics, precision oncology, pharmacogenomics and rare-disease diagnostics
- Years
- 2011–
- Lifecycle status
- active
- Status basis
- The predecessor Medical Genetics Program was established in 2011; the integrated model reported 2022-2024 outcomes in Nature Genetics and KFSHRC in February 2026.
- Status evidence date
- 2026-02-01
- Scale
- Testing rose from about 22,000 tests in 2022 to more than 44,000 in 2024; more than 5,000 precision-oncology analyses; about 8,000 ClinVar submissions and 3,000 Arab-specific variants reported.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- King Faisal Specialist Hospital & Research Centre (KFSHRC) Genomic Medicine Center of Excellence
- Partner organizations
- Global Alliance for Genomics and Health
- Organism / population
- KFSHRC patients across clinical specialties
03 / Data and access
What exists and how it can be reached.
Data types
- clinical genome and exome testing
- precision-oncology profiling
- pharmacogenomics
- EHR integration
- AI and bioinformatics
- ClinVar submissions
Data access
Clinical/controlled; aggregate outcomes and selected ClinVar variants public
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Nationally significant integrated clinical-genomics infrastructure with independently published operational metrics and continuing expansion.
Editorial note
Umbrella/capacity record. Metrics aggregate child programs such as PGT, fetal screening, pharmacogenomics, oncology and exome services; do not sum them as distinct participants. Start year refers to the predecessor Medical Genetics Program.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0